At Techinvention Lifecare Pvt. Ltd., our commitment to consumer safety is unwavering. If you experience an adverse event from our product, tell your healthcare provider and then report it to us using the contact details below, enabling us to continuously monitor the safety profile of our products and take action whenever required.
The vaccine is a liquid formulation of Oral Cholera Vaccine containing O1 and O139 of Vibrio cholerae inactivated by heat or formalin. The vaccine was developed by EuBiologics Co., Ltd, South Korea with the help of International Vaccine Institute (IVI), Korea. The vaccine fulfils the recommendations stipulated in WHO guidelines for Cholera Vaccine.
Prevention of Cholera caused by Vibrio cholerae but the efficacy against Vibrio cholerae serogroup O139 was not demonstrated.
Manufactured by: Eubiologics Co., Ltd.
Marketed by: TechInvention Lifecare Pvt. Ltd.
Your privacy is important to us.
All AE reports shall be handled with strict confidentiality.
Personal information is protected and used solely for safety monitoring purposes.
For any questions or to report an Adverse Event, please contact our AE Reporting team:
© 2023 TechInvention. Developed by Scivision Solutions Pvt. Ltd.